Walgreen's Sales Slide Continues

Walgreens_logoDrug store giant Walgreen Co. (NYSE: WAG) announced this morning that December same-store sales fell 6.1% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 4% from $6.99 billion last year to $6.71 billion.

Pharmacy sales in December fell 4.9%, and same-store pharmacy sales fell 8.9%. Pharmacy sales accounted for 56.7% of monthly sales.

Walgreen noted that a calendar shift was responsible for a negative impact of 2.3% on pharmacy sales, following a 2.9% drop in November. Sales of generic drugs as opposed to brand-name drugs cost the store 3.2% in comparable sales.

There was some positive news. The number of flu shots administered this year has risen from 5.3 million a year ago to 5.5 million. An increase in flu this year has boosted same-store drug sales by 1.4%, and the additional flu shots added 0.7% to sales in December.

Walgreen's stock is down 0.8% this morning, at $37.50 in a 52-week range of $28.53 to $38.41, as virtually every metric reported today was down.


Filed under: 24/7 Wall St. Wire, Retail Tagged: WAG
Read Full Story

Markets

DJIA 21,580.07 -31.71 -0.15%
NASDAQ 6,387.75 -2.25 -0.04%
S&P 500 2,472.54 -0.91 -0.04%
NIKKEI 225 19,975.67 -124.08 -0.62%
HANG SENG 26,832.09 126.00 0.47%
DAX 12,195.26 -44.80 -0.37%
USD (per EUR) 1.16 0.00 -0.38%
USD (per CHF) 0.95 0.00 0.25%
JPY (per USD) 110.82 -0.12 -0.11%
GBP (per USD) 1.30 0.00 0.06%

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.